fenofibrate has been researched along with n-oleoylethanolamine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Alexander, SP; Bennett, AJ; Garle, MJ; Gibson, CL; Hewitt, K; Kendall, DA; Murphy, SP; Sun, Y | 1 |
Chen, L; Fu, J; Li, L; Lin, X; Qiu, Y; Ren, J; Xu, Y | 1 |
4 other study(ies) available for fenofibrate and n-oleoylethanolamine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism.
Topics: Animals; Arachidonic Acids; Benzoxazines; Cannabinoids; Cerebral Cortex; Cyclooxygenase 2; Dronabinol; Endocannabinoids; Fatty Acids, Unsaturated; Fenofibrate; HeLa Cells; Humans; I-kappa B Kinase; Ligands; Luciferases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Naphthalenes; Neuroprotective Agents; Oleic Acids; Polyunsaturated Alkamides; PPAR alpha; Protein Binding; Recombinant Fusion Proteins; Transfection | 2007 |
Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats.
Topics: Animals; Diet, High-Fat; Endocannabinoids; Fatty Acids; Fenofibrate; Hep G2 Cells; Humans; Hypolipidemic Agents; Lipid Metabolism; Lipogenesis; Male; Non-alcoholic Fatty Liver Disease; Oleic Acids; Oxidation-Reduction; PPAR alpha; Rats, Sprague-Dawley; RNA, Messenger | 2015 |